Featured Publications
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma (2021)
Frede, J., Anand, P., Sotudeh, N. et al. Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myeloma. Nat Cell Biol (2021).
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma (2021)
Waldschmidt, J.M., Kloeber, J.A., Anand, P. et al. Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma. Clin Cancer Res October 14 2021 DOI: 10.1158/1078-0432.CCR-21-2040
Waldschmidt, J.M., Kloeber, J.A., Anand, P. et al. Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in BRAF-Mutated Multiple Myeloma. Clin Cancer Res October 14 2021 DOI: 10.1158/1078-0432.CCR-21-2040
Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencing (2018)
Guo, G., Raje, N.S., Seifer, C. et al. Genomic discovery and clonal tracking in multiple myeloma
by cell-free DNA sequencing. Leukemia 32, 1838–1841 (2018).
Click HERE for a complete list of publications